DEN240047 is the FDA 510(k) clearance record for Allix5, a class II device, cleared for Clairity, Inc. on under FDA product code SEZ (Radiological Software Device To Predict Future Breast Cancer Risk). FDA's definition for product code SEZ reads: "A radiological software device to predict future breast cancer risk is a device that analyzes radiological images generated by breast imaging modalities and/or inputs derived from radiological images to provide qualified healthcare...". FDA records list one 510(k) clearance for Clairity, Inc. As of , FDA records show no recalls naming DEN240047.
Clearance record
- Decision date
- Received
- (266 days to decision)
- Product code
- SEZ Radiological Software Device To Predict Future Breast Cancer Risk
- Regulation
- 21 CFR 892.8500
- Device class
- Class II
- Review panel
- Radiology
- Applicant
- Clairity, Inc. 201 W 5th St., Suite 1500, Austin TX
- Third party review
- No
Clearances, product code SEZ
Trailing 12 monthsFDA records hold no clearances under product code SEZ in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
